A #DNA-based #vaccine candidate for #COVID_19 worked by using engineered bacteriophage can be delivered through a #nasal_spray.
Production of the #virus_like_particle (VLP) is the first step in developing a #vaccine for #COVID_19, which will now undergo preclinical testing for safety and efficacy by Medicago.
#Ad5_nCoV is a genetically engineered #vaccine candidate with the replication-defective #adenovirus type 5 as a vector to express the spike protein of the novel #coronavirus (SARS-CoV-2).
The first step in the clinical development of #Moderna's #mRNA vaccine against #SARS_CoV_2 (mRNA-1273) is being conducted by #NIH under its own Investigational New Drug application.
New #COVID_19 vaccine candidate has been developed using proprietary #recombinant_protein nanoparticle technology platform to generate antigens derived from the #coronavirus spike (S) protein.
